Pharmicell Co., Ltd. (005690.KS) KSC

14,860.00

+0(+0.00%)

Updated at December 24 03:30PM

Currency In KRW

Valuation

Market Cap496.83B
Enterprise Value489.26B
P/E Ratio31.05
PEG Ratio0.8
Price/Sales Ratio8.84
Price/Book Ratio8.09
Enterprise/Revenue8.73
Enterprise/EBITDA27.02

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.29
Operating Margin0.28

Management Effectiveness

Return On Assets0.22
Return On Equity0.29

Income Statement

Revenue64.85B
Revenue/Share1,678.79
Gross Profit21.33B
EBITDA9.43B
Net Income6.33B
Diluted EPS105.51

Balance Sheet

Total Cash37.28B
Total Cash/Share620.25
Total Debt8.56B
Total Debt/Equity0.08
Current Ratio10.82
Book Value Per Share1,837.07

Price History

52-Week Change85.75
52-Week High20,800
52-Week Low7,150
Moving Average 50 Days16,478.6
Moving Average 200 Days12,786.75

Statistics

Average Volume3.42M
Shares Outstanding60M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate20
Trailing Annual Dividend Yield0.13
Payout Ratio0.04
Last Split Factor531:500
Last Split DateApril 30, 2012